The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).

Psychopharmacology

Volumn 171, Issue 2, 2004, Pages 231-233

  Parrott, A C ^a   Rodgers, J ^a   Buchanan, T ^a   Scholey, A B ^a   Heffernan, T ^a   Ling, J ^a  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; PSYCHEDELIC AGENT; STREET DRUG;

ANIMAL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HUMAN; METABOLISM; NOTE; PARKINSON DISEASE; PRIMATE; PSYCHOMOTOR DISORDER;

ANIMALS; CLINICAL TRIALS; DOPAMINE; HALLUCINOGENS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PARKINSON DISEASE, SECONDARY; PRIMATES; PSYCHOMOTOR DISORDERS; STREET DRUGS;

EID: 3142675240     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1600-1     Document Type: Note

References (0)